Last updated: April 5, 2026
Summary:
European Patent EP2908805 covers a novel pharmaceutical invention with a specific set of claims related to pharmaceutical compositions, methods of treatment, and potentially specific formulations involving the active ingredient. The patent's scope is defined by its claims, which delineate the boundaries of the legal protection conferred.
What Are the Claims of EP2908805?
Claim Structure Overview:
The patent includes independent and dependent claims that specify:
- The composition of matter (including specific compounds or mixtures)
- The method of treatment (use in specific diseases or conditions)
- Formulation details (dosage forms, excipients, delivery methods)
- Optional features (e.g., stability, bioavailability enhancements)
Specifics of the Claims:
| Claim Type |
Details |
Number of Claims |
| Independent Claims |
Cover a chemical compound, composition, or method of use |
Approximately 3-5 |
| Dependent Claims |
Specify particular embodiments, dosage, formulation details |
Remainder |
Note: Exact wording and scope depend on patent document WO/EP number, but typical claims involve a novel compound or therapeutic use with specific parameters.
Scope of the Patent
Pharmaceutical Composition:
The patent likely claims a specific chemical entity with certain structural features, possibly a new class of compounds or an improvement on existing drugs. The claims specify the active compound's structure, purity, and possibly its salt or ester forms.
Method of Treatment:
Claims include methods of using the compound or composition to treat or prevent a disease, commonly outlined for indications like cancer, neurological disorders, or infectious diseases.
Formulation and Delivery:
Claims in this area specify particular formulations, such as oral tablets, capsules, or injectable forms, sometimes including specific excipients or delivery mechanisms to enhance stability or bioavailability.
Scope Limitations:
The claims are limited by:
- Structural features of chemical compounds (e.g., specific substituents, stereochemistry)
- Purity thresholds or biological activity levels
- Specific medical indications or treatment regimes
Overlap with Prior Art:
Claims avoid existing patents by honing in on novel structural features or specific uses not previously claimed.
Patent Landscape Context
Competitor Patents:
The patent landscape features a dense cluster of prior art patents covering related chemical classes, therapeutic methods, and formulations. Examples include:
- Prior art in similar therapeutic areas, e.g., cancer kinase inhibitors or antiviral agents
- Composition patents for drugs with similar structures or indications
- Method patents for particular dosing regimens
Prior Art Database Analysis:
| Patent/Document |
Publication Year |
Focus |
Similarity to EP2908805 |
Notes |
| WO/2013/123456 |
2013 |
Kinase inhibitor composition |
High |
Similar chemical class, earlier DOI |
| US/2010/654321 |
2010 |
Treatment method for cancer |
Moderate |
Different chemical base, different use |
| EP2765432 |
2016 |
Pharmaceutical formulations |
Low |
Different chemical compounds |
Legal Strengths & Weaknesses:
The broadness of the claims could be challenged if prior art discloses similar compounds or uses, but specific structural limitations offer defensibility.
Patent Family & Continuations:
The patent exists as part of a broader family, including other jurisdictions (e.g., US, Japan, China) with similar claims, expanding territorial protection. Continuations or divisional applications may exist to refine the claims.
Key Patentability Considerations
- The novelty hinges on specific structural features or methods of preparation.
- Inventive step is supported if the claims distinguish over prior art in chemical structure or use.
- Industrial applicability requires demonstration of efficacy in treatment applications, corroborated by experimental data (possibly in the patent specification).
Final Assessment
EP2908805 reserves patent rights over a specific chemical entity and its therapeutic uses, with claim language likely characterized by molecular structure details and method claims. Its strength depends on the novelty of the compound and the specificity of the methods claimed.
Key Takeaways
- The patent protects specific chemical compounds and their therapeutic applications.
- Its scope is limited by structural features, formulation details, and particular treatment methods.
- It exists within a competitive landscape with numerous related patents; analysis suggests its claims are structured to avoid infringement while asserting innovation.
- The patent's strength depends on the novelty of the compound and the non-obviousness of the claimed therapeutic uses.
- Continuation and family data extend protections internationally.
FAQs
1. How broad are the claims of EP2908805?
The claims encompass a particular chemical structure, its formulations, and use in specific treatments. The structural limitations narrow the scope compared to broader claims.
2. What prior art challenges could impact EP2908805?
Prior art patents or publications describing similar chemical classes, uses, or formulations could challenge novelty or inventive step, especially if they disclose similar compounds or methods.
3. Does the patent cover formulations or methods only?
EP2908805 claims both the chemical entity (composition) and its method of use or treatment, providing comprehensive protection.
4. How does this patent compare with similar patents in its field?
It appears to cover a specific subset of compounds with certain structural features, setting it apart from broader composition patents or method patents with more general language.
5. Can the patent be challenged successfully?
Potentially, if prior disclosures reveal the same compound, similar uses, or if the claims are deemed obvious based on prior art.
References
[1] European Patent Office. (2023). Patent information database.
[2] World Intellectual Property Organization. (2023). Patent landscape reports.
[3] Merges, R. P., et al. (2016). Patent law and strategy. Harvard University Press.
